Menu
GeneBe

rs398122988

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_014495.4(ANGPTL3):c.363_367del(p.Asn121LysfsTer3) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000435 in 1,552,802 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00031 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00045 ( 0 hom. )

Consequence

ANGPTL3
NM_014495.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 7.61
Variant links:
Genes affected
ANGPTL3 (HGNC:491): (angiopoietin like 3) This gene encodes a member of a family of secreted proteins that function in angiogenesis. The encoded protein, which is expressed predominantly in the liver, is further processed into an N-terminal coiled-coil domain-containing chain and a C-terminal fibrinogen chain. The N-terminal chain is important for lipid metabolism, while the C-terminal chain may be involved in angiogenesis. Mutations in this gene cause familial hypobetalipoproteinemia type 2. [provided by RefSeq, Aug 2015]
DOCK7 (HGNC:19190): (dedicator of cytokinesis 7) The protein encoded by this gene is a guanine nucleotide exchange factor (GEF) that plays a role in axon formation and neuronal polarization. The encoded protein displays GEF activity toward RAC1 and RAC3 Rho small GTPases but not toward CDC42. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-62597921-GAACTC-G is Pathogenic according to our data. Variant chr1-62597921-GAACTC-G is described in ClinVar as [Pathogenic]. Clinvar id is 91866.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-62597921-GAACTC-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ANGPTL3NM_014495.4 linkuse as main transcriptc.363_367del p.Asn121LysfsTer3 frameshift_variant 1/7 ENST00000371129.4
DOCK7NM_001367561.1 linkuse as main transcriptc.1683-11302_1683-11298del intron_variant ENST00000635253.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ANGPTL3ENST00000371129.4 linkuse as main transcriptc.363_367del p.Asn121LysfsTer3 frameshift_variant 1/71 NM_014495.4 P1
DOCK7ENST00000635253.2 linkuse as main transcriptc.1683-11302_1683-11298del intron_variant 5 NM_001367561.1 Q96N67-1

Frequencies

GnomAD3 genomes
AF:
0.000309
AC:
47
AN:
152008
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000263
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000530
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.000252
AC:
51
AN:
202196
Hom.:
0
AF XY:
0.000228
AC XY:
25
AN XY:
109456
show subpopulations
Gnomad AFR exome
AF:
0.000132
Gnomad AMR exome
AF:
0.000634
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000344
Gnomad OTH exome
AF:
0.000215
GnomAD4 exome
AF:
0.000448
AC:
628
AN:
1400676
Hom.:
0
AF XY:
0.000413
AC XY:
286
AN XY:
692810
show subpopulations
Gnomad4 AFR exome
AF:
0.0000980
Gnomad4 AMR exome
AF:
0.000388
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000391
Gnomad4 NFE exome
AF:
0.000541
Gnomad4 OTH exome
AF:
0.000382
GnomAD4 genome
AF:
0.000309
AC:
47
AN:
152126
Hom.:
0
Cov.:
32
AF XY:
0.000309
AC XY:
23
AN XY:
74378
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.000262
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000530
Gnomad4 OTH
AF:
0.000474
Alfa
AF:
0.000396
Hom.:
0
Bravo
AF:
0.000461

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

ANGPTL3-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesSep 11, 2023The ANGPTL3 c.363_367del5 variant is predicted to result in a frameshift and premature protein termination (p.Asn121Lysfs*3). This variant also results in a frameshift in the ANGPTL3 gene, which is transcribed on the opposite strand (c.363_367del; p.Asn121Lysfs*3). To our knowledge, this variant has not been reported in association with DOCK7-related disease. In relation to ANGPTL3, this variant has been reported in several individuals with autosomal recessive hypobetalipoproteinemia (see for example Martín-Campos et al. 2012. PubMed ID: 22155345; Blanco-Vaca et al. 2019. PubMed ID: 30782561). This variant is reported in 0.061% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-63063592-GAACTC-G). This variant is interpreted as pathogenic for autosomal recessive hypobetalipoproteinemia and likely benign for DOCK7-related disease. -
Developmental and epileptic encephalopathy, 23 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeDec 29, 2021This sequence change creates a premature translational stop signal (p.Asn121Lysfs*3) in the ANGPTL3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ANGPTL3 are known to be pathogenic (PMID: 22247256, 24058201). This variant is present in population databases (rs569107562, gnomAD 0.05%). This premature translational stop signal has been observed in individual(s) with familial combined hypolipidemia (PMID: 22155345, 22247256, 24058201). It has also been observed to segregate with disease in related individuals. This variant is also known as p.N121Lx2. ClinVar contains an entry for this variant (Variation ID: 91866). For these reasons, this variant has been classified as Pathogenic. -
Familial hypobetalipoproteinemia 2 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMMar 22, 2012- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs398122988; hg19: chr1-63063592; API